Related Experiment Video
Updated: Aug 25, 2026
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Smokeless tobacco: current status and future directions
D Hatsukami1, R Nelson, J Jensen
1University of Minnesota, Department of Psychiatry, Minneapolis 55422.
Abstract:
Smokeless tobacco is addicting, can cause physical dependence, and is associated with many health risks. In spite of these concerns over its use, minimal research has been conducted to understand the effects from and factors associated with smokeless tobacco use. Additionally, relatively few studies have examined potentially effective treatments for the smokeless tobacco user. This paper reviews the existing literature in this area and considers future directions for research.
Insights
Smokeless tobacco use poses significant health risks and addiction concerns. More research is needed on its effects, contributing factors, and effective cessation treatments for smokeless tobacco users.
Area of Science:
- Public Health
- Addiction Medicine
- Tobacco Control
Background:
- Smokeless tobacco (ST) is addictive and linked to numerous health risks.
- Despite concerns, research on ST use effects and associated factors is limited.
- Few studies have explored effective treatments for ST dependence.
Purpose of the Study:
- To review existing literature on smokeless tobacco.
- To identify research gaps concerning ST use.
- To propose future research directions for ST cessation.
Main Methods:
- Literature review of scientific publications.
- Synthesis of current knowledge on ST.
- Identification of research needs and future directions.
Main Results:
- Significant gaps exist in understanding ST's health effects and user factors.
- Limited evidence base for effective ST cessation interventions.
- Urgent need for more research in ST addiction and treatment.
Conclusions:
- Further research is critical to address the public health impact of smokeless tobacco.
- Development and evaluation of targeted ST cessation strategies are necessary.
- Future studies should focus on ST's specific risks, user profiles, and treatment efficacy.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:29Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...